16 / April / 2026 Psyllium: Why do we still not fully understand its effects on the body? Used since antiquity, the compound can now be found in dietary supplements By Editorial staff
07 / April / 2026 Agonists and antagonists: drugs to modulate body signals From asthma inhalers to monoclonal antibodies: how drugs “talk” to cells By Yasmim Cunha
06 / March / 2026 Protein design: how scientists are creating tailor-made molecules to tackle major challenges Using computational models and AI, scientists are developing proteins to address scientific and technological problems By Samuel Fernandes
16 / February / 2026 Polylaminins and laminin: Understanding the difference and their role in the placenta during pregnancy Each protein has distinct characteristics that influence the body in specific ways By Editorial staff
08 / January / 2026 The challenge of including expectant mothers in clinical trials Fewer than 1% of clinical trials in the USA include pregnant women, creating knowledge gaps on the use of medications during gestation By Marília Marasciulo
10 / November / 2025 Pioneering bacteria form microbiome in babies’ intestines British genome study identifies three bacterial species that initiate gut colonization in newborns, offering potential for the development of personalized probiotics By Editorial staff
16 / September / 2025 Graphene foam reconnects spinal cord in rats A light, conductive material favors neural regeneration in spinal injuries, and may inspire new treatments for paralyses By Editorial staff
12 / September / 2025 Psyllium: Health benefits and research gaps Supplement may contribute to intestinal and cardiovascular health, but well-founded studies on efficacy and side effects are needed By Bruno de Pierro
11 / September / 2025 Polylaminin and pathways toward regenerating the spinal cord After 25 years of research, a substance developed at UFRJ shows potential to restore movement in patients with complete spinal cord injuries By Diogo Rodriguez
09 / September / 2025 Arteries on chips: Recent technology may speed up testing of new cardiovascular treatments Device developed in Holland faithfully simulates human blood vessels in preclinical studies By Editorial staff
